Benjamin F. Edwards & Company Inc. raised its stake in Steris Plc (NYSE:STE) by 3.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,550 shares of the medical equipment provider’s stock after buying an additional 318 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in Steris Plc were worth $778,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Legato Capital Management LLC boosted its position in shares of Steris Plc by 6,926.1% in the first quarter. Legato Capital Management LLC now owns 5,944,248 shares of the medical equipment provider’s stock valued at $85,578,000 after buying an additional 5,859,646 shares during the period. BlackRock Inc. boosted its position in Steris Plc by 16,597.1% in the first quarter. BlackRock Inc. now owns 5,272,105 shares of the medical equipment provider’s stock worth $366,200,000 after buying an additional 5,240,530 shares during the last quarter. Wellington Management Group LLP boosted its position in Steris Plc by 77.8% in the first quarter. Wellington Management Group LLP now owns 6,529,610 shares of the medical equipment provider’s stock worth $453,547,000 after buying an additional 2,856,744 shares during the last quarter. American Century Companies Inc. boosted its position in Steris Plc by 18.9% in the first quarter. American Century Companies Inc. now owns 2,071,740 shares of the medical equipment provider’s stock worth $143,903,000 after buying an additional 328,635 shares during the last quarter. Finally, Prudential Financial Inc. boosted its position in Steris Plc by 470.7% in the first quarter. Prudential Financial Inc. now owns 344,755 shares of the medical equipment provider’s stock worth $23,947,000 after buying an additional 284,350 shares during the last quarter. 92.40% of the stock is owned by hedge funds and other institutional investors.
Shares of Steris Plc (NYSE STE) opened at 85.13 on Friday. The stock has a 50 day moving average of $83.11 and a 200 day moving average of $75.64. Steris Plc has a 12 month low of $63.80 and a 12 month high of $87.49. The firm has a market cap of $7.26 billion, a price-to-earnings ratio of 60.89 and a beta of 1.33.
Steris Plc (NYSE:STE) last announced its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.05. The business had revenue of $608 million during the quarter, compared to the consensus estimate of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The business’s revenue was down 4.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.79 EPS. On average, equities research analysts expect that Steris Plc will post $4.06 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.46%. The ex-dividend date is Friday, August 25th. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s dividend payout ratio (DPR) is currently 80.00%.
TRADEMARK VIOLATION WARNING: This report was reported by BNB Daily and is the property of of BNB Daily. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.baseball-news-blog.com/2017/08/19/benjamin-f-edwards-company-inc-has-778000-stake-in-steris-plc-nyseste-updated-updated.html.
A number of research analysts have weighed in on STE shares. Zacks Investment Research raised shares of Steris Plc from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. KeyCorp raised shares of Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price objective for the company in a report on Wednesday, May 3rd. BidaskClub cut shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Raymond James Financial, Inc. lifted their price objective on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, August 9th. Finally, Wellington Shields cut shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $86.75.
In other Steris Plc news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $80.05, for a total transaction of $800,500.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Sudhir K. Pahwa sold 800 shares of the firm’s stock in a transaction dated Thursday, May 25th. The shares were sold at an average price of $77.28, for a total transaction of $61,824.00. The disclosure for this sale can be found here. Insiders sold a total of 46,354 shares of company stock valued at $3,805,772 in the last quarter. Insiders own 2.55% of the company’s stock.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.